Skip to the page

Data / Form D filings / Arbela Laboratories, Inc.

Arbela Laboratories, Inc.: Form D filing

Arbela Laboratories, Inc., a company in Randolph, NJ, filed a Form D with the SEC in 2024. The latest, on April 1, 2024, reports $575,000 sold of a $1.5 million offering to 12 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
41 WILKESHIRE BLVD., Randolph, NJ, 07869
Phone
(518) 588-6042
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 504, Rule 506(b), Securities Act section 4(a)(5)
SEC identifier (CIK)
2013446

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 1, 2024New notice$1,500,000$575,000$925,00012Mar 18, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael LoCascioExecutive Officer, Director, Promoter

Other companies in New Jersey that filed recently

Every Form D from the week of Apr 1, 2024 · All recent filings in New Jersey · All recent Other filings

Read from SEC EDGAR. Amount sold is what Arbela Laboratories, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.